2-碘-5-(三氟甲基)苄醇 |
702641-05-2 |
C8H6OF3I |
托法替尼 |
477600-75-2 |
C16H20N6O |
Z-L-缬胺酸 |
158257-41-1 |
C14H15NO5 |
Tofacitinib |
540737-29-9 |
C16H20N6O.C6H8O7 |
(R)-叔丁基 (1-([1,1'-联苯]-4-基)-3-羟基丙烷-2-基)氨基甲酸酯 |
1426129-50-1 |
C20H25NO3 |
2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮 |
184177-83-1 |
C30H35N5O3 |
(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸 |
1012341-50-2 |
C23H29NO4 |
[2-[(3R,5R-3,5-双[叔丁基二甲基硅氧基]环己烯]乙基]二苯基磷氧 |
139356-39-1 |
C32H51O3Si2P |
艾沙康唑-活性化合物 |
241479-67-4 |
437.46 |
双(叔丁基二甲基硅基)-反式-钙泊三醇 |
112849-27-1 |
C39H68O3Si2 |
(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol |
128387-35-9 |
C34H62O3Si2 |
骨化二醇中间体 |
147125-14-2 |
C33H56O3Si |